Evidence quality 4.38/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 4/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 4/5
- D4 Uncertainty
- 4/5
- D5 Scope
- 5/5
- D6 Prose
- 5/5
- D7 Perception honesty
- 3/5
- D8 Caveat completeness
- 5/5
≈ As likely as
Perceived
Dementia in public discourse is largely synonymous with Alzheimer's disease. The other major subtypes — vascular dementia, Lewy body dementia, frontotemporal dementia (FTD) — are rarely part of lay understanding, which means the roughly 30–40% of dementia that is not Alzheimer's tends to surprise families at diagnosis. Perceived risk of non-Alzheimer's dementia specifically is low, partly because the term "non-Alzheimer's" is itself an unfamiliar category. Awareness of MCI (mild cognitive impairment) as a potential precursor state is also low, despite its prevalence of 12–18% among adults over 65.
Source: editorial intuition, not polled
Actual
6 in 100 adults reaching 65 will develop non-Alzheimer's dementia in their remaining lifetime
adults aged 65+ in high-income countries (derived from Lancet Commission 2024, ADI 2023)
Show derivation
The Lancet Commission on Dementia Prevention 2024 (Livingston et al.) estimates approximately 40–42% lifetime risk of any dementia for adults in high-income countries, consistent with Fang et al. 2025 (US ARIC cohort, lifetime from 55). Earlier estimates from Alzheimer's Association US data (lifetime from 65) were approximately 21% for women and 12% for men. Non-Alzheimer's subtypes account for approximately 30–40% of all dementia diagnoses. Using the Alzheimer's Association 2024 figures as the more conservative base: women: 21% × 35% = 7.4%; men: 12% × 35% = 4.2%; sex-averaged (55% women / 45% men at 65+): 0.55 × 7.4 + 0.45 × 4.2 = 6.0%. The headline figure (0.06) reflects this sex-pooled estimate from age 65. The much higher Fang 2025 figure (42% for any dementia from 55) applies to a longer horizon from a younger starting age and is cited for context. Uncertainty low (0.04): conservative, using lower non-AD fraction (30%) and male-skewed population. High (0.10): using Fang 2025 any-dementia rate times 35% non-AD fraction, from age 55.
Caveats: The 6% headline is a sex-pooled estimate from age 65 in high-income countries. N…
The 6% headline is a sex-pooled estimate from age 65 in high-income countries. Non-Alzheimer's dementia is a heterogeneous category: vascular dementia (step-wise decline, linked to strokes), Lewy body dementia (hallucinations, Parkinson-like features), and frontotemporal dementia (personality and language changes, earlier onset, average age 60) have distinct presentations, trajectories, and treatment approaches. Mixed pathology — Alzheimer's pathology co-occurring with vascular damage or Lewy bodies — is found in a substantial fraction of autopsy studies, meaning the categorical boundaries used in life are imprecise. The lifetime risk for any dementia is approximately 3.5× higher (21% for women from 65); the non-Alzheimer's fraction is the subset not captured by the better-known figure. Mild cognitive impairment (MCI, prevalence ~12–18% at 65+) is not dementia; 10–15% of MCI cases per year convert to dementia, but many do not.
Related risks
Other risks on similar themes — for exploring related fears.
Benzo dependence
What are the odds of developing benzodiazepine dependence after a standard prescription?
Bipolar disorder
What are the odds of developing bipolar disorder at some point in your lifetime?
Pick challenger
Alzheimer’s disease dominates public understanding of dementia — but 30 to 40% of dementia cases belong to other categories. Vascular dementia, caused by strokes or chronic small-vessel disease, tends to progress in a step-wise pattern tied to vascular events rather than the gradual slope of Alzheimer’s. Lewy body dementia is distinguished by visual hallucinations, sleep disturbance, and Parkinson-like motor features. Frontotemporal dementia affects personality and language more than memory and strikes at a younger average age, often in the late fifties or early sixties. The Alzheimer’s Disease International estimates that approximately 55 million people worldwide are currently living with dementia, of whom roughly 30–40% have a non-Alzheimer’s type as their primary diagnosis.
For adults reaching 65 in high-income countries, a reasonable estimate of the lifetime risk for non-Alzheimer’s dementia is approximately 6% — derived by applying the non-Alzheimer’s fraction (~35%) to the age-65 dementia estimates for women (~21%) and men (~12%) and pooling. The Lancet Commission on Dementia (2024), which now identifies 14 modifiable risk factors accounting for nearly half of all cases, estimates a broader lifetime risk of ~40% for any dementia from age 55 in high-income populations; the non-Alzheimer’s share of that figure would be higher (~14%). The honest interpretation: the risk is genuinely uncertain and depends on the starting age, the population, and the diagnostic threshold used.
Mild cognitive impairment (MCI) occupies an important but misunderstood position in this picture. MCI is prevalent — affecting roughly 12 to 18% of adults over 65 — and roughly 10 to 15% of MCI cases convert to a dementia diagnosis each year. But the majority of MCI cases at any given time are stable or resolve, making MCI a risk marker rather than a diagnosis of progressive disease. The critical methodological caveat is mixed pathology: autopsy studies consistently find that many people die with combinations of Alzheimer’s, vascular, and Lewy body changes simultaneously, which means the diagnostic categories applied during life imperfectly map onto the biological reality.
Related tidbits
6 in 100 adults reaching 65 will develop non-Alzheimer's dementia in their remaining lifetime: vascular, Lewy body, frontotemporal. The fact that the diagnosis often is not Alzheimer's tends to surprise families.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
1/3 sources independently verified verbatim against the cited source
-
[1] The Lancet — Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Dementia prevention, intervention, and care: 2024 report of the Lancet standing CommissionSee all 2 Likelier entries citing this source →
- Statistic
Lifetime dementia risk approximately 40–42% in high-income countries; 14 modifiable risk factors now account for ~45% of cases- Excerpt
“"Dementia affects over 55 million people worldwide, with 10 million new cases annually. The lifetime risk for individuals in high-income countries is estimated at approximately 40% from age 55, with women at higher risk than men. Non-Alzheimer's dementias, including vascular dementia, Lewy body disease, and frontotemporal dementia, together account for approximately 30–40% of all dementia diagnoses." ”
- Source data from
- 2024-08-10
- Accessed
- 2026-05-04
- Calculation
- Livingston et al. 2024 — the third Lancet Commission on dementia (following 2017 and 2020 reports). Provides the global prevalence figure (55 million), the annual incidence (10 million), and the lifetime risk estimate of ~40% in HIC. The 30–40% non-Alzheimer's fraction is applied to the more conservative Alzheimer's Association age-65 base (women 21%, men 12%) to derive the native rate. This avoids double- counting with the higher Fang 2025 lifetime-from-55 figure.
-
[2] Alzheimer's Disease International (ADI) — World Alzheimer Report 2023: Reducing Dementia Risk
World Alzheimer Report 2023: Reducing Dementia Risk- Statistic
55 million people globally living with dementia in 2023; vascular, Lewy body, and frontotemporal types account for 30–40% of cases; worldwide numbers project to 139 million by 2050- Excerpt
“"In 2023, approximately 55 million people worldwide are living with dementia, with nearly 60–70% of cases attributable to Alzheimer's disease. Vascular dementia represents approximately 20% of cases, Lewy body dementia 10–15%, and frontotemporal dementia 5–10%. Mixed pathology, typically Alzheimer's co-occurring with vascular damage, is found in a substantial proportion of autopsy cases." ”
- Source data from
- 2023-09-01
- Accessed
- 2026-05-04 · archived copy
- Calculation
- ADI World Alzheimer Report 2023 provides the 55 million global prevalence figure and the subtype breakdown (AD 60–70%, vascular 20%, Lewy body 10–15%, FTD 5–10%). The non-AD fraction (30–40%) is derived from these proportions and applied in the calculation above. The ADI report is the principal global reference for dementia epidemiology outside of country-specific surveys.
-
[3] Nature Medicine — Lifetime risk and projected burden of dementia Verified
Lifetime risk and projected burden of dementia- Statistic
Lifetime risk of dementia after age 55 was 42% (95% CI 41–43) in the US ARIC community-based cohort- Excerpt
“"This is a community-based, prospective cohort study with 15,043 participants (26.9% Black race, 55.1% women and 30.8% with at least one apolipoprotein E4 (APOE ε4) allele). The lifetime risk of dementia after age 55 years was 42% (95% confidence interval: 41–43). Rates were substantially higher in women, Black adults and APOE ε4 carriers, with lifetime risks ranging from approximately 45% to 60% in these populations." ”
- Source data from
- 2025-01-13
- Accessed
- 2026-05-04 · archived copy
- Verification
- Excerpt independently re-fetched and confirmed word-for-word against the cited source during our grounding audit.
- Calculation
- Fang et al. 2025 (Nature Medicine, published 13 Jan 2025; led by Fang at Johns Hopkins and Coresh at NYU) — a single US community-based prospective cohort, the Atherosclerosis Risk in Communities (ARIC) study, with 15,043 participants free of dementia at age 55. Lifetime risk after age 55 was 42% (women 48%, men 35%). This from-age-55 horizon explains why it exceeds the Alzheimer's Association age-65 estimate (women 21%, men 12%). The entry uses the more conservative age-65 base for the headline rate; the Fang 2025 figure is cited in context for completeness. Non-AD fraction applied: 42% × 35% = 14.7%, which sets the uncertainty.high (0.10 is conservative relative to this; 0.15 would use it directly from age 55).